203 related articles for article (PubMed ID: 37536407)
1. Therapeutic potential of lectins in the treatment of breast cancer: A review.
Bektas S; Kaptan E
Int J Biol Macromol; 2023 Sep; 249():126073. PubMed ID: 37536407
[TBL] [Abstract][Full Text] [Related]
2. Lectin-Carbohydrate Interactions: Implications for the Development of New Anticancer Agents.
de Oliveira Figueiroa E; Albuquerque da Cunha CR; Albuquerque PBS; de Paula RA; Aranda-Souza MA; Alves MS; Zagmignan A; Carneiro-da-Cunha MG; Nascimento da Silva LC; Dos Santos Correia MT
Curr Med Chem; 2017 Nov; 24(34):3667-3680. PubMed ID: 28545372
[TBL] [Abstract][Full Text] [Related]
3. Breast Cancer Treatment: A Review.
Waks AG; Winer EP
JAMA; 2019 Jan; 321(3):288-300. PubMed ID: 30667505
[TBL] [Abstract][Full Text] [Related]
4. Lectins as a promising therapeutic agent for breast cancer: A review.
Singh K; Agrawal L; Gupta R; Singh D; Kathpalia M; Kaur N
Breast Dis; 2024; 43(1):193-211. PubMed ID: 38905027
[TBL] [Abstract][Full Text] [Related]
5. Detection of aberrant glycosylation in breast cancer using lectin histochemistry.
Carter TM; Brooks SA
Methods Mol Med; 2006; 120():201-16. PubMed ID: 16491603
[TBL] [Abstract][Full Text] [Related]
6. Man-Specific Lectins from Plants, Fungi, Algae and Cyanobacteria, as Potential Blockers for SARS-CoV, MERS-CoV and SARS-CoV-2 (COVID-19) Coronaviruses: Biomedical Perspectives.
Barre A; Van Damme EJM; Simplicien M; Le Poder S; Klonjkowski B; Benoist H; Peyrade D; Rougé P
Cells; 2021 Jun; 10(7):. PubMed ID: 34203435
[TBL] [Abstract][Full Text] [Related]
7. Halilectin-3, a Lectin from the Marine Sponge Haliclona caerulea, Induces Apoptosis and Autophagy in Human Breast Cancer MCF7 Cells Through Caspase-9 Pathway and LC3-II Protein Expression.
do Nascimento-Neto LG; Cabral MG; Carneiro RF; Silva Z; Arruda FVS; Nagano CS; Fernandes AR; Sampaio AH; Teixeira EH; Videira PA
Anticancer Agents Med Chem; 2018; 18(4):521-528. PubMed ID: 29141557
[TBL] [Abstract][Full Text] [Related]
8. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
9. Molecular Mechanisms Involved in the Antitumor Activity of Isolated Lectins from Marine Organisms: A Systematic Review.
Ferreira HJ; de Almeida EM; da Silva WMB; Teixeira EH; do Nascimento Neto LG
Curr Drug Targets; 2020; 21(6):616-625. PubMed ID: 31763966
[TBL] [Abstract][Full Text] [Related]
10. Classification, Treatment Strategy, and Associated Drug Resistance in Breast Cancer.
Tang Y; Wang Y; Kiani MF; Wang B
Clin Breast Cancer; 2016 Oct; 16(5):335-343. PubMed ID: 27268750
[TBL] [Abstract][Full Text] [Related]
11. Nucleolin-binding by ErbB2 enhances tumorigenicity of ErbB2-positive breast cancer.
Wolfson E; Goldenberg M; Solomon S; Frishberg A; Pinkas-Kramarski R
Oncotarget; 2016 Oct; 7(40):65320-65334. PubMed ID: 27542246
[TBL] [Abstract][Full Text] [Related]
12. Glycosylation-Dependent Induction of Programmed Cell Death in Murine Adenocarcinoma Cells.
Parshenkov A; Hennet T
Front Immunol; 2022; 13():797759. PubMed ID: 35222379
[TBL] [Abstract][Full Text] [Related]
13. On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis.
Gorelik E; Galili U; Raz A
Cancer Metastasis Rev; 2001; 20(3-4):245-77. PubMed ID: 12085965
[TBL] [Abstract][Full Text] [Related]
14. Lectin binding to normal and malignant breast tissue.
Leathem A; Dokal I; Atkins N
Diagn Histopathol; 1983; 6(3-4):171-80. PubMed ID: 6373198
[TBL] [Abstract][Full Text] [Related]
15. Animal lectins: potential antitumor therapeutic targets in apoptosis.
Liu Z; Zhang Q; Peng H; Zhang WZ
Appl Biochem Biotechnol; 2012 Oct; 168(3):629-37. PubMed ID: 22826026
[TBL] [Abstract][Full Text] [Related]
16. mTOR inhibitors in advanced breast cancer: ready for prime time?
Martin LA; André F; Campone M; Bachelot T; Jerusalem G
Cancer Treat Rev; 2013 Nov; 39(7):742-52. PubMed ID: 23557794
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer cells respond differently to docetaxel depending on their phenotype and on survivin upregulation.
De Iuliis F; Salerno G; Giuffrida A; Milana B; Taglieri L; Rubinacci G; Giantulli S; Terella F; Silvestri I; Scarpa S
Tumour Biol; 2016 Feb; 37(2):2603-11. PubMed ID: 26392111
[TBL] [Abstract][Full Text] [Related]
18. Efficacy studies of Sclerotium rolfsii lectin on breast cancer using NOD SCID mouse model.
Hegde P; Narasimhappagari J; Swamy BM; Inamdar SR
Chem Biol Drug Des; 2018 Aug; 92(2):1488-1496. PubMed ID: 29675931
[TBL] [Abstract][Full Text] [Related]
19. Blockade of the HER family of receptors in the treatment of HER2-positive metastatic breast cancer.
Sachdev JC; Jahanzeb M
Clin Breast Cancer; 2012 Feb; 12(1):19-29. PubMed ID: 21903480
[TBL] [Abstract][Full Text] [Related]
20. Triple-negative breast cancer: current state of the art.
Rastelli F; Biancanelli S; Falzetta A; Martignetti A; Casi C; Bascioni R; Giustini L; Crispino S
Tumori; 2010; 96(6):875-88. PubMed ID: 21388048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
